Published in Med Care on January 01, 1991
Randomised clinical trials in general practice: lessons from a failure. BMJ (1991) 5.35
Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg (2005) 2.00
Management of lung cancer. Thorax (1996) 1.68
The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. British Columbia/Ontario Working Group. Br J Cancer (1997) 1.25
Evaluation of medical audit. J Epidemiol Community Health (1994) 1.24
Medical practice guidelines. West J Med (1994) 1.16
Audit of compliance with antenatal protocols. BMJ (1992) 1.13
The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer (2007) 1.08
An audit of distribution and use of guidelines for management of head injury. Qual Health Care (1993) 1.02
Practice setting and physician influences on judgments of colon cancer treatment by community physicians. Health Serv Res (1996) 0.88
Inappropriate Halsted mastectomy and patient volume in Italian hospitals. Am J Public Health (1993) 0.83
Documentation of preventive screening interventions by general practitioners: a retrospective chart audit. BMC Fam Pract (2010) 0.77
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet (2000) 8.10
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15
Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70
The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care (2001) 3.67
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
Consumer participation in research and health care. BMJ (1997) 3.38
What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17
A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14
Stopping a trial early in oncology: for patients or for industry? Ann Oncol (2008) 3.06
Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74
International Quality of Life Assessment (IQOLA) Project. Qual Life Res (1992) 2.64
Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package. JAMA (1995) 2.62
ASA Physical Status and age predict morbidity after three surgical procedures. Ann Surg (1994) 2.52
Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol (1993) 2.44
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18
Quality of systematic reviews used in guidelines for oncology practice. Ann Oncol (2006) 2.15
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98
Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis (2009) 1.95
Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep (1986) 1.91
Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med (2011) 1.75
Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75
A European version of the Appropriateness Evaluation Protocol. Goals and presentation. The BIOMED I Group on Appropriateness of Hospital Use. Int J Technol Assess Health Care (1999) 1.73
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer (2006) 1.70
Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.69
Does a drug do better when it is new? Ann Oncol (2002) 1.61
Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59
Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med (2005) 1.59
Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.58
Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant (1999) 1.57
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst (2010) 1.55
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking indicators for family members living with people with diabetes. Diabet Med (2013) 1.55
Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol (2001) 1.51
Pediatric risk of mortality: an assessment of its performance in a sample of 26 Italian intensive care units. Crit Care Med (1998) 1.50
Essential requirements for practice guidelines at national and local levels. Neurol Sci (2004) 1.49
A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46
Classification of radical hysterectomy adopted by the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer. Int J Gynecol Cancer (2007) 1.44
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study. Ann Oncol (1994) 1.43
The risk of bias from omitted research. BMJ (2000) 1.43
Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol (1998) 1.43
The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. Eur Heart J (2001) 1.41
The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer. Ann Oncol (1990) 1.40
Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.39
Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer (1994) 1.36
Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01. J Clin Oncol (2003) 1.33
Effects of new smoking regulations in Italy. Ann Oncol (2005) 1.32
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care--healthcare professional perspective. Diabet Med (2013) 1.30
A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol (1993) 1.30
Impact of different customization strategies in the performance of a general severity score. Crit Care Med (1997) 1.30
One model, several results: the paradox of the Hosmer-Lemeshow goodness-of-fit test for the logistic regression model. J Epidemiol Biostat (2000) 1.26
Promoting consumers' demand for evidence-based medicine. Int J Technol Assess Health Care (1998) 1.24
Etoposide (VP-16-213). Current status of an active anticancer drug. N Engl J Med (1985) 1.23
Practice guidelines: useful and "participative" method? Survey of Italian physicians by professional setting. Arch Intern Med (2001) 1.22
Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med (2008) 1.20
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer (2007) 1.20
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol (1997) 1.19
Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study. Eur J Cancer (2006) 1.17
The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes. Diabetes Care (2001) 1.17
Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe? Ann Oncol (2013) 1.16
Subjective health status assessment: evaluation of the Italian version of the SF-12 Health Survey. Results from the MiOS Project. J Epidemiol Biostat (2001) 1.15
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2000) 1.13
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study. Gynecol Oncol (1995) 1.12
Evaluation of the uniformity of fit of general outcome prediction models. Intensive Care Med (1998) 1.10
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med (2013) 1.10
Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer (2000) 1.09
Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance. Ann Oncol (2010) 1.09
An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol (1998) 1.09
Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. Int J Obes (Lond) (2007) 1.09
The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer. Am J Public Health (1991) 1.07
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin. Br J Cancer (2012) 1.06
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer (2007) 1.04
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol (2003) 1.04
Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. Int J Gynecol Cancer (2003) 1.04
The burden of hospitalization related to diabetes mellitus: a population-based study. Nutr Metab Cardiovasc Dis (2011) 1.03
Appropriateness of hospital use: an overview of Italian studies. Int J Qual Health Care (1995) 1.03
The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol (2002) 1.03
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer (1995) 1.02
Appropriateness and variation of surgical treatment of breast cancer in Italy: when excellence in clinical research does not match with generalized good quality care. Progetto Oncologia Femminile. J Clin Epidemiol (1995) 1.01